stuck
Established Member
Moderator note:
Copied from this thread:
"Cerebral blood flow is reduced in ME/CFS during head-up tilt testing even in the absence of hypotension or tachycardia... van Campen et al, 2020
_____________________________
There is this new article but sorry if it is old study news, I'm new to posting -- thought it was apropos:
https://www.eurekalert.org/pub_releases/2020-02/nu-tso022720.php
News Release 28-Feb-2020
The article, "Dual microglia effects on blood brain barrier permeability induced by systemic inflammation," was published in the journal Nature Communications at DOI: 10.1038/s41467-019-13812-z.
https://www.nature.com/articles/s41467-019-13812-z
Copied from this thread:
"Cerebral blood flow is reduced in ME/CFS during head-up tilt testing even in the absence of hypotension or tachycardia... van Campen et al, 2020
_____________________________
There is this new article but sorry if it is old study news, I'm new to posting -- thought it was apropos:
https://www.eurekalert.org/pub_releases/2020-02/nu-tso022720.php
News Release 28-Feb-2020
Two sides of a coin: Our own immune cells damage the integrity of the blood-brain barrier
Nagoya University
IMAGE: Microglia express tight junction molecule (CLDN5) to maintain BBB integrity in early phase and molecule for phagocytosis (CD68) to impair the BBB function in late phase of systemic inflammation. Microglia... view more
Credit: Hiroaki Wake
The blood-brain barrier is a layer of cells that covers the blood vessels in the brain and regulates the entry of molecules from the blood into the brain. Increases in blood-brain barrier "permeability," or the extent to which molecules leak through, are observed in several neurological and psychiatric disorders; therefore, understanding the regulation of blood-brain barrier permeability is crucial for developing better therapies for such disorders.
In a study recently published in Nature Communications, a research team led by Prof. Hiroaki Wake of Nagoya University Graduate School of Medicine shows that microglia -- the resident immune cells of the brain -- initially protect the blood-brain barrier from damage due to "systemic inflammation," a condition of chronic inflammation associated with factors like smoking, ageing, and diabetes, and leading to an increased risk of neurodegenerative disorders. However, these same microglia can change their behavior and increase the blood-brain barrier permeability, thereby damaging it.
...
The article, "Dual microglia effects on blood brain barrier permeability induced by systemic inflammation," was published in the journal Nature Communications at DOI: 10.1038/s41467-019-13812-z.
https://www.nature.com/articles/s41467-019-13812-z
Abstract
Microglia survey brain parenchyma, responding to injury and infections. Microglia also respond to systemic disease, but the role of blood–brain barrier (BBB) integrity in this process remains unclear. Using simultaneous in vivo imaging, we demonstrated that systemic inflammation induces CCR5-dependent migration of brain resident microglia to the cerebral vasculature. Vessel-associated microglia initially maintain BBB integrity via expression of the tight-junction protein Claudin-5 and make physical contact with endothelial cells. During sustained inflammation, microglia phagocytose astrocytic end-feet and impair BBB function. Our results show microglia play a dual role in maintaining BBB integrity with implications for elucidating how systemic immune-activation impacts neural functions.
Last edited by a moderator: